Behçet’s disease causes aggressive immune attacks with few regenerative options. This project proposes a new therapy using umbilical cord stem cells, spiny mouse regeneration cues, and immune reprogramming. The goal is to shift T helper 17 (TH17) pathways from inflammation toward healing. TH17 cells are known drivers of chronic inflammation in Behçet’s, and modulating their response may open the door to tissue repair. Funding will support outreach, expert feedback, and prep for testing.